Bringing the fundamentals into focus…
Bringing the fundamentals into focus…
MEDP · against 115 other Healthcare companies of similar size
Ranked #73 of 116 · scores higher than 37% of peers · safety percentile 26
Bars: peers in each 10-point band of the safety percentile (higher = safer; 67+ earns the lower-risk grade)21 peers with a safety percentile of 20–29, including MEDP · Click a bar to see the companies
Mainly because of its current ratio and beta, which are weaker than most Healthcare peers.
Risk is relative to the sector, not a bankruptcy probability. Banks and brokers carry high leverage by design, and share buybacks can shrink equity and current assets, which raises debt/equity on paper.
| Metric | MEDP | Peer median | Better than | Position among peers | Weight |
|---|---|---|---|---|---|
| Debt / equityLower is better · 112 reported | 0.33× | 0.41× | 54% | 33% | |
| BetaLower is better · 114 reported | 1.18 | 0.71 | 17% | 33% | |
| Current ratioHigher is better · 110 reported | 0.73× | 1.96× | 1% | 33% |
| Rank | Company | Market cap | Safety | Overall |
|---|---|---|---|---|
| 1 | 10.1B EUR (≈$11.1B) | 99 | ||
| 2 | 10.2B USD | 97 | ||
| 3 | 9.8B USD | 96 | ||
| 4 | 26.0B USD | 93 | 28 | |
| 5 | 12.6B USD | 89 | ||
| 69 | 27.3B USD | 28 | 55 | |
| 70 | 18.2B USD | 28 | 40 | |
| 71 | 14.9B USD | 28 | 65 | |
| 72 | 27.5B EUR (≈$30.2B) | 27 | 60 | |
| 73 | 18.5B USD | 26 | 62 | |
| 74 | 28.7B USD | 26 | 52 | |
| 75 | 34.6B USD | 25 | 58 | |
| 76 | 10.7B USD | 25 | 65 | |
| 77 | 154.4B BRL (≈$27.8B) | 23 | 43 |
Scores are sector-relative percentiles from the latest snapshot, always calculated against the whole sector: narrowing the comparison group changes who you compare with, not the scores. Missing metrics are left out and the remaining weights rescaled. How we score